Inovio Pharmaceuticals (INO) Falls on Rumor of Drug Test Failure
Shares of pharmaceutical research company Inovio Pharmaceuticals, Inc. (INO) fell on Tuesday against the backdrop of a higher day for the markets overall. The stock fell $1.44 per share, down 13.36%, to close at $9.34. The activity came on volume of 11,407,818 shares, compared to average daily volume of 1.521 million shares. The stock fell after The Street's Adam Feuerstein suggested that studies conducted on a promising new drug may have failed.